JMDCFRA:6JM +0.59%77 Return-on-Tangible-Equity is 56.66% as of Mar. 2026, which is 34% above its 10-year median of 42.41. GuruFocus rates FRA:6JM with a GF Score™ of 77/100 and a GF Value™ of €30.53 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 580 Healthcare Providers & Services companies, JMDC ranks better than 82.24% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. JMDC's annualized net income for the quarter that ended in Mar. 2026 was €42.6 Mil. JMDC's average shareholder tangible equity for the quarter that ended in Mar. 2026 was €75.2 Mil. Therefore, JMDC's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 56.66%.
The historical rank and industry rank for JMDC's Return-on-Tangible-Equity or its related term are showing as below:
FRA:6JM'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 33.33 Med: 42.41 Max: 117.99
Current: 53.53
During the past 10 years, JMDC's highest Return-on-Tangible-Equity was 117.99%. The lowest was 33.33%. And the median was 42.41%.
FRA:6JM's Return-on-Tangible-Equity is ranked better than 82.24% of 580
companies
in the Healthcare Providers & Services industry
Industry Median: 10.065
vs FRA:6JM: 53.53
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
JMDC Return-on-Tangible-Equity Related Terms
JMDC Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for JMDC's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:6JM vs VEEV, BTSG, TEM: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, JMDC's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMDC Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JMDC's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where JMDC's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 56.66% mean?
JMDC (FRA:6JM) has a Return-on-Tangible-Equity of 56.66% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on JMDC and its competitors. This is 34% above median its historical median of 42.41. Over the past decade, JMDC's Return-on-Tangible-Equity has ranged from 33.33 to 117.99. According to the industry distribution chart, JMDC ranks #103 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 17.8%.
Is JMDC's Return-on-Tangible-Equity too high?
JMDC's current Return-on-Tangible-Equity of 56.66% is 34% above median its 10-year median of 42.41. Over the past 10 years, this metric has ranged from a low of 33.33 to a high of 117.99. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.07. JMDC's value of 56.66% is 462.9% above this industry median. Based on the distribution chart, JMDC ranks #103 out of 580 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, JMDC has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JMDC's Return-on-Tangible-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, JMDC ranks #103 out of 580 companies for Return-on-Tangible-Equity. This places JMDC in the top 18% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.07. JMDC's value of 56.66% is 462.9% above this benchmark. Historically, JMDC's own Return-on-Tangible-Equity has ranged from 33.33 to 117.99 over the past decade. While the company's 10-year median is 42.41 vs. the industry median of 10.07, JMDC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.07, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMDC's current Return-on-Tangible-Equity of 56.66% is 462.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on JMDC and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMDC's current Return-on-Tangible-Equity is 56.66%, which is 34% above median its own 10-year median of 42.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMDC stock overvalued right now?
Based on GuruFocus' analysis, JMDC (FRA:6JM) is currently considered Significantly Undervalued. The stock's GF Value™ is €30.53, compared to a current price of €17.10 — trading 44% below its estimated fair value. The current Return-on-Tangible-Equity is 56.66%, which is 34% above median its 10-year median of 42.41 and 462.9% above the Healthcare Providers & Services industry median of 10.07. JMDC's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For JMDC (FRA:6JM), the current Return-on-Tangible-Equity is 56.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMDC (FRA:6JM) Overvalued in 2026?
Based on GuruFocus' analysis, JMDC stock appears to be undervalued.
The current stock price of €17.10 is trading 44% below its estimated GF Value™ of €30.53.
GuruFocus considers JMDC to be Significantly Undervalued.
Key valuation signals for FRA:6JM:
Return-on-Tangible-Equity: 56.66% (34% above median its 10-year median of 42.41)
GF Value™: €30.53 vs. price of €17.10 (44% below fair value)
Industry Position: 462.9% above the Healthcare Providers & Services median (#103 of 580)
No single metric tells the full story. See the FRA:6JM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMDC Inc is engaged in constructing and providing a medical database, offering PHR and other health promotion services, telemedicine such as diagnostic imaging, and providing digital solutions to dispensing pharmacies.
77GF Score
Get the complete analysis for FRA:6JM
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6JM has been successfully added to your 
